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Abstract 
Objectives: We used multidetector computed tomography (MDCT) to study the relation 
between culprit plaque characteristics and post-percutaneous coronary intervention (PCI) 
cardiac troponin T (cTnT) elevation. 
Background: PCI is often complicated by post-procedural myocardial necrosis manifested 
by elevated cardiac biomarkers. 
Methods: Stable angina patients (n=107) with normal pre-PCI cTnT levels underwent 
64-slice MDCT before PCI to evaluate plaque characteristics of culprit lesions. Patients were 
divided into 2 groups according to presence (Group I, n=36) or absence (Group II, n=71) of 
post-PCI cTnT elevation ≥3× the upper limit of normal (0.010 ng/mL) at 24 hours after PCI. 
Results: CT attenuation values were significantly lower in Group I than in Group II (43.0 
[26.5-75.7] vs 94.0 [65.0-109.0] HU, p<0.001). Remodeling index (RI) was significantly 
greater in Group I than in Group II (1.20 ± 0.18 vs 1.04 ± 0.15, p<0.001). Spotty calcification 
was observed significantly more frequently in Group I than in Group II (50% vs 11%, 
p<0.001). Multivariate analysis showed presence of positive remodeling (RI >1.05) (odds 
ratio [OR], 4.54; 95% confidence interval [CI], 1.36-15.9; p=0.014) and spotty calcification 
(OR, 4.27; 95% CI, 1.30-14.8; p=0.016) were statistically significant independent predictors 
for cTnT elevation. For prediction of cTnT elevation, the presence of all 3 variables (CT 
attenuation value <55 HU, RI >1.05, and spotty calcification) showed a high positive 
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predictive value of 94 %, and their absence showed a high negative predictive value of 90%. 
Conclusions: MDCT may be useful in detecting which lesions are at high risk for myocardial 
necrosis after PCI. 
Key Words: multidetector computed tomography; coronary plaque; troponin; stents. 
Abbreviations and Acronyms 
ACS = acute coronary syndrome 
CSA = cross-sectional area 
cTnT = cardiac troponin T 
EEM = external elastic membrane 
IVUS = intravascular ultrasound 
MDCT = multidetector computed tomography 
PCI = percutaneous coronary intervention 
PR = positive vessel remodeling 
RI = remodeling index 
SAP = stable angina pectoris 
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Introduction 
Percutaneous coronary intervention (PCI) may be complicated by post-procedural myocardial 
injury/infarction as manifested by elevated cardiac biomarkers such as creatine kinase 
(CK)-MB or troponin T. The occurrence of post-procedural myocardial injury/infarction has 
been shown to be associated with worse short- and long-term clinical outcome (1,2) and even 
mild elevation of cardiac troponin after PCI has been related to a worse prognosis (3). 
Intravascular ultrasound (IVUS) has shown that post-procedural myocardial injury/infarction 
is caused by lesions with ruptured plaques and/or those with a greater plaque burden (4). 
Virtual histology IVUS also has shown that post-PCI cardiac troponin (cTnT) elevation 
occurs in lesions with a large necrotic core area and positive vessel remodeling (PR) (5). 
Multidetector computed tomography (MDCT) is a promising technique for noninvasive 
coronary angiography. With the development of MDCT, it is possible not only to detect 
coronary artery stenosis (6,7) but also to evaluate coronary plaque quality and quantity such 
as can be done with IVUS (8,9). Motoyama et al. showed that the CT characteristics of 
culprit lesions in acute coronary syndrome (ACS) included PR, low-attenuation plaques, and 
spotty calcification (10) and that the patients with these 2 plaque characteristics of PR and 
low-attenuation plaques on CTA were at a higher risk of developing ACS than were patients 
without these characteristics during follow-up (11). Recently, Uetani et al. (12) reported that 
post-procedural myocardial injury/infarction was associated with the volume and fraction of 
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low-attenuation plaques detected by MDCT. However, a previous study exploring potential 
prognostic predictors of cardiovascular events on MDCT showed that mixed lesions were 
associated with adverse events on follow-up (13). Thin-cap fibroatheromas on virtual 
histology IVUS were most prevalent in mixed plaques, suggesting a higher degree of 
vulnerability of these mixed plaques on MDCT (14). 
Therefore, we hypothesized that the plaque with MDCT characteristics of low 
attenuation plaques, PR, and spotty calcification has the potential to predict an elevation of 
cTnT after PCI. The aim of this study was to investigate the clinical value of PR and spotty 
calcification in conjunction with low-attenuation plaques on MDCT to predict post-PCI cTnT 
elevation. 
Methods 
Study Population. The study population comprised 107 patients who were diagnosed as 
having stable coronary artery disease by 64-slice MDCT before PCI from April 2009 to 
August 2010 at our institution. We included patients with stable angina pectoris (SAP) with 
normal pre-PCI cTnT levels (15) and excluded patients with ST-segment elevation 
myocardial infarction and unstable AP. We also excluded patients with severely calcified 
lesions, motion artifacts, previously stented lesions, and chronic total occlusions, for which 
coronary plaque quantity and degree of stenosis are difficult to evaluate by MDCT. 
Study Protocol. All patients underwent 64-slice MDCT to evaluate coronary plaque 
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characteristics of the culprit lesion before PCI and serial measurements of cTnT before PCI 
and at 24 hours post procedure. According to cTnT blood test results, the patients were 
divided into 2 groups according to the presence (Group I, n =36) or absence (Group II, n =71) 
of post-PCI TnT elevation ≥3× the upper limit of normal (0.010 ng/mL) at 24 hours after PCI.  
MDCT Protocol. Scanning was performed with a Philips Brilliance-64 scanner (Philips 
Medical Systems, Cleveland, OH) with 64×0.625-mm detector configuration. Scanning was 
performed at 120 kV and 600-1050 mA, 0.2 pitch, and with standard or sharp filters. 
Estimated effective radiation dose was 11 mSv. Reconstruction was routinely performed 
using a window centered at 75% of the R–R interval to coincide with left ventricular diastasis. 
A volume of 60 mL of contrast agent (iopamidol 370 mg/mL; Schering AG) was injected 
intravenously at a rate of 4 mL/s. As soon as the signal density level in the ascending aorta 
reached a predefined threshold of 100 Hounsfield units (HU), acquisition of CT data and an 
electrocardiogram trace were automatically started during a 7 to 9-s breath-hold. The patients 
were given oral metoprolol (20 mg) 1 h before the scheduled scan if their heart rate was >70 
beats/min, and all patients received sublingual nitroglycerin (0.3 mg) 5 min before the scan. 
MDCT Analysis. Analysis of the scans was performed using a Brilliance Workspace 3-D 
workstation (Philips Medical Systems). Images were initially reconstructed at mid-diastolic 
phase (75% of R-R interval) of the cardiac cycle. In some cases, additional reconstructions 
were made at different time points of the R–R interval. Each scan was analyzed 
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independently by 2 experienced readers unaware of the patient’s identity, clinical presentation, 
biomarker analysis, and PCI procedure. Image display settings for lumen and plaque 
quantification were determined according to previously published data (16). 
We measured the vessel diameter and lesion length, the cross-sectional area (CSA) of the 
external elastic membrane (EEM) and target lesion, and the lumen CSA of the proximal and 
distal vessel references using axial images and multiplanar reconstruction images. CT density 
values of the culprit plaque were measured from at least 3 points, and averaged this. 
Remodeling index (RI) was defined as the EEM CSA of the target lesion / the average of the 
EEM CSAs of the proximal and distal references. We assessed adherent calcium deposits in 
or adjacent to each plaque by determining their presence or absence and morphology as 
follows according to previously described methods: diffuse, length (L) of calcium burden 
≥3/2 of vessel diameter and width ≥2/3 of vessel diameter; medium, length ≥3/2 of vessel 
diameter and width <2/3 of vessel diameter or length <3/2 of vessel diameter and width ≥2/3 
of vessel diameter; spotty, length <3/2 of vessel diameter and width <2/3 of VD (17). We 
classified the plaque into three types, namely non-calcified, calcified, and mixed plaque (18). 
A ring-like enhancement was defined as either the presence of a ring of high attenuation 
around certain coronary artery plaques or the CT attenuation of a ring presenting higher than 
those of the adjacent plaque and no greater than 130 HU (19). 
PCI Procedures. All patients received treatment with aspirin (200 mg/day) and clopidogrel 
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(75 mg/day) at least 24 h before the procedure. A glycoprotein IIb/IIIa receptor inhibitor is 
not yet available in Japan. PCI was performed through either the radial or femoral artery 
using a 6 French catheter. Before starting the procedure, 6000–10000 units of heparin were 
given intravenously, and the activated clotting time was maintained at >300 s. Once the guide 
wire passed through the culprit lesion, balloon dilatation or stent placement was performed. 
The treatment was regarded as successful when the luminal diameter of the target lesion 
increased by at least by 50%, residual stenosis was less than 30%, and the Thrombolysis In 
Myocardial Infarction (TIMI) flow was grade 3 (20). Transient no reflow was defined as an 
angiogram showing a deterioration of coronary flow of TIMI grade 0, 1, or 2 during the 
procedure, regardless of the timing, and TIMI grade 3 at the final angiogram (21).  
Statistical Analysis. All data are expressed as the mean ± SD or median and interquartile 
range for non-normally distributed data. Comparisons of continuous variables were analyzed 
by unpaired t-test or Mann-Whitney U test according to the data distribution. Comparisons of 
categorical variables between groups were performed by chi-square test without correction 
for multiplicity. Inter- and intraobserver agreements were performed by linear regression 
analyses for continuous variables and kappa (κ) test for categorical variables. 
Receiver-operating characteristic (ROC) analysis was used to determine optimal cut-off 
values of CT attenuation value and RI for prediction of post-PCI cTnT elevation. The best 
cut-off value was defined as the point with the highest sum of sensitivity and specificity. 
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Results displayed for univariate analysis were based on clinically relevant and 
laboratory-based variables and lesion characteristics. Multivariate logistic regression analysis 
was then developed to calculate odds ratios (ORs) and 95% confidence intervals (CIs). We 
performed stepwise forward selection considering any valuables with values of p <0.20 to 
identify potential risk factors for post-PCI cTnT elevation. The sensitivity, specificity, 
positive and negative predictive values (PPV and NPV), and diagnostic accuracy of the CT 
characteristics alone or in combination were calculated for prediction of post-PCI cTnT 
elevation. A p value of <0.05 was considered to indicate statistical significance.  
Results 
Patient, Lesion, and Procedural Characteristics. Patients were divided into 2 groups 
according to the presence (Group I, n = 36) or absence (Group II, n = 71) of post-PCI cTnT 
elevation ≥3× the upper limit of normal (0.010 ng/mL) at 24 hours after PCI. Baseline patient 
characteristics are summarized in Table 1. There were no statistically significant differences 
in the clinical characteristics and medications between the two groups. The median post-PCI 
cTnT levels were significantly higher in patients in Group I than in Group II (0.088 
[0.037-0.289] vs 0.010 [0.010-0.014] ng/mL, p<0.001). Angiographic findings and 
procedural results are summarized in Table 2. All lesions were treated with stent implantation. 
There were no statistically significant differences in target vessels, type B2/C lesions, 
bifurcation lesions, number of stents implanted, and stent size between the two groups. 
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Transient no reflow was observed significantly more frequently in Group I than in Group II 
(16% vs 2%, p = 0.012). 
MDCT Measurements in the Culprit Lesion. Representative images from patients in 
Group I and II are presented in Figure 1 and 2, respectively. Fifty randomly selected lesions 
were measured by two observers. Inter- and intraobserver measurements of CT attenuation 
value (r = 0.92, p <0.0001 and r = 0.93, p <0.0001, respectively) and RI (r = 0.83, p <0.0001 
and r = 0.87, p <0.0001, respectively) were closely correlated, and mean differences in CT 
attenuation value (0.75 ± 1.58 HU and 2.09 ± 1.31 HU, respectively) and RI (-0.017 ± 0.013 
and 0.004 ± 0.011, respectively) were small. Agreement (κ) for the interpretation of spotty 
calcification was 0.90 and 0.92, respectively. According to the ROC analysis, the best cutoff 
points of CT attenuation value was 55 HU, with a sensitivity of 69% and a specificity of 80%, 
and RI was 1.05, with a sensitivity of 80% and a specificity of 68% for prediction of 
post-cTnT elevation. Therefore, we defined the CT attenuation value of <55 HU as the lower 
plaque density and RI of >1.05 as the PR. Lesion characteristics on MDCT are listed in Table 
2. The CT attenuation value of the culprit plaque was significantly lower in Group I than in 
Group II (43.0 [26.5-75.7] vs 94.0 [65.0-109.0] HU, p <0.001), and presence of PR (80% vs 
32%, p <0.001), and lesion length (16.7 ± 4.2 vs 14.1 ± 5.1 mm, p =0.012) were significantly 
greater in Group I than in Group II. The prevalence of any coronary plaque subtype and any 
calcified subtype with the presence or absence of post-PCI cTnT elevation is in Figure 3. 
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Mixed plaques (64% vs 31%, p <0.001) and spotty calcification (50% vs 11%, p <0.001) 
were observed significantly more frequently in Group I than in Group II, whereas 
noncalcified plaques (33% vs 61%, p <0.001) were observed significantly less frequently in 
Group I than in Group II. Plaque with ring-like enhancement was observed significantly more 
frequently in Group I than in Group II (31% vs 11%, p =0.016). 
Univariate and Multivariate Analysis for Prediction of Post-PCI cTnT Elevation. 
Post-PCI cTnT elevation was observed in 36 of the 107 patients (33.6%) in this study. 
According to the univariate analysis (Table 3), lesion length, PR, CT attenuation, and spotty 
calcification were significantly associated with post-PCI cTnT elevation. Multiple logistic 
regression analysis showed that the presence of PR (OR 4.54; 95% CI 1.36-15.9; p = 0.014) 
and spotty calcification (OR 4.27; 95% CI 1.30-14.8; p = 0.016) were statistically significant 
independent predictors for post-PCI cTnT elevation after adjustment for multiple 
confounders. 
Diagnostic Accuracy of CT Characteristics for Prediction of Post-PCI cTnT Elevation. 
The sensitivity, specificity, PPV and NPV, and diagnostic accuracy of each CT characteristic 
alone or in combination are shown in Table 4. Presence of all 3 characteristics (CT <55 HU, 
RI >1.05, and spotty calcification) showed a high PPV of 94%, and absence of all 3 showed a 
high NPV of 90% for predictive value of cTnT elevation. 
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Discussion 
Importantly, our study demonstrated a direct relation between pre-PCI plaque composition by 
MDCT and PMI in SAP patients. Post-PCI cTnT elevation ≥3× the upper limit of normal was 
observed in 33.6% of patients with SAP. The presence of positive remodeling and spotty 
calcification were the significant predictors of post-PCI cTnT elevation. For prediction of 
post-PCI cTnT elevation, the presence of all 3 CT characteristics showed a high PPV of 94%, 
and their absence offered a high NPV of 90% for the exclusion of culprit lesions by 
noninvasive MDCT imaging. 
Relation Between Plaque Characteristics on MDCT and cTnT Elevation. Cardiac 
biomarker cTnT is sensitive and specific for detection of myocardial damage. Porto et al. 
found that the cause of periprocedural myocardial necrosis after PCI was the impairment of 
flow in coronary side branches and distal embolization of atheromatous or thrombotic 
materials (22). Therefore, pre-PCI plaque composition may have an impact on myocardial 
injury/infarction during PCI. However, there are few published data regarding the relation 
between pre-PCI plaque composition by MDCT and post-PCI cardiac biomarker levels. 
Nakagawa et al. reported that patients who experienced transient no-reflow during PCI had 
lower plaque CT density values in culprit lesions (23). Uetani et al. demonstrated that 
post-procedural myocardial injury was associated with the volume and fraction of 
low-attenuation plaques by MDCT (12). In the present study, CT attenuation value of <55 
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HU was associated with post-PCI cTnT elevation. While in earlier studies, a mean CT density 
of 14-47 HU was found in lipid-rich plaque (8, 24, 25), Pohle et al. showed a mean density of 
58 HU (median 53) (26) and Leber et al. reported that a low CT density value (49 ± 22 HU) is 
considered to correspond to soft plaque identified on IVUS (16). This difference most likely 
results from the natural course of atherosclerotic plaque or slice thickness and contrast 
medium concentration that affect plaque density measurements (27, 28). It will be possible to 
use our cutoff point of CT attenuation value <55 HU for prediction of post-PCI cTnT 
elevation clinically. 
Predictive Value for Detection of cTnT Elevation. In the present study, PR and spotty 
calcification were significant predictors of post-PCI cTnT elevation. Furthermore, presence 
of all 3 CT characteristics (CT attenuation value <55 HU, RI >1.05, and spotty calcification) 
showed a high PPV of 94%, and their absence showed a high NPV of 90%. PR has been 
associated with plaque vulnerability in clinical studies. A previous report of an IVUS study 
confirmed that PR (RI >1.05) was an important factor in the culprit lesion (29). 
Histopathological characteristics of ruptured plaques showed the same characteristics of the 
vulnerable plaques. Plaque rupture occurred not only in patients with unstable AP or 
myocardial infarction but also in those with SAP. The rupture site has larger arterial wall and 
lumen areas and more PR (30). Another histopathological report showed that coronary 
plaques with PR had a higher lipid content and macrophage count (31), which indicated 
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plaque vulnerability. Ehara et al. found by IVUS study that small calcium deposits were 
present with significant frequency in the culprit lesion segments in patients with ACS (32). 
Burke et al. reported that autopsy data showed the degree of calcification was greatest for 
acute and healed plaque ruptures and the least for plaque erosion. Calcification in coronary 
atherosclerosis is associated with one type of plaque instability, namely plaque rupture (33). 
The data in the present study showed that some SAP patients have spotty calcification and 
that plaque with spotty calcification was one of the predictors of post-PCI cTnT elevation. A 
previous MDCT study showed that mixed lesions were associated with adverse events on 
follow-up (13). Thin-cap fibroatheromas on virtual histology IVUS were most prevalent in 
mixed plaques, suggesting a higher degree of vulnerability of these mixed plaques on MDCT 
(14). In the present study, we found that mixed plaques with low-attenuation plaques, PR, and 
spotty calcification have the potential to predict an elevation of cTnT after PCI. We also 
demonstrated that none of the conventional risk factors allowed differentiation between the 
post-PCI cTnT elevation and the elevation free group. These findings were in agreement with 
a previous MDCT study by Motoyama et al. (11) and were also supported by recent 
near-infrared spectroscopy data (34). 
Clinical Implications. These data suggest that it would be worthwhile to consider the 
identification of these vulnerable plaques by MDCT before PCI. If the plaque has the 
characteristics of low plaque density, PR, and spotty calcification, a plan for prevention of 
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post-PCI cTnT elevation can be made before the PCI procedure. Further efforts to minimize 
procedural events may require aggressive attempts to prevent distal embolization (35). As for 
medications, Kawai et al. reported that intravenous administration of nicorandil before PCI 
can prevent slow coronary flow phenomenon (36). A single high loading dose (80 mg) of 
atorvastatin administered within 24 hours of PCI reduces the incidence of periprocedural MI 
in elective PCI (37). Therefore, the use of these medicines during or before the procedure 
might the possibility of preventing post-procedural myocardial injury/infarction in the 
perioperative period. 
Study Limitation. First, we acknowledge that because of the relatively small sample size in 
the present study, our findings should be confirmed in a larger number of patients. Second, 
we excluded patients with severely calcified lesions in this study. In general, SAP patients 
frequently have more severe coronary artery calcification in their coronary arteries than do 
ACS patients. If we included these patients in this study, it is probable that the occurrence of 
post-PCI cTnT elevation would be lower than that of our presented data. Third, CT plaque 
density can be altered by the concentration of the contrast agent administered or by contrast 
type, regardless of the presence or absence of calcification near the plaque and of the model 
of CT used. Finally, we consider it necessary to investigate the relation between the MDCT 
image and histopathology and to confirm the correspondence between these imaging 
characteristics and histopathologic findings. 
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Conclusion. The present MDCT study showed that post-PCI cTnT elevation occurred in 
lesions with low-attenuation plaques, PR, and spotty calcification in patients with SAP. 
MDCT may play an important role in detecting which lesions are at high risk for myocardial 
necrosis after PCI. 
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Figure Legend. 
Figure 1. The CT characteristics of a culprit lesion in the 52-year-old male patient with 
post-PCI TnT elevation ≥3× the upper limit of normal. Coronary angiogram (A) and 
multiplanar reconstructed image (B) show severe stenosis in the mid right coronary artery. 
Cross-sectional images show the proximal reference (C), culprit lesion (D), and distal 
reference (E). The lesion has positive remodeling (RI: remodeling index 1.28), spotty 
calcification, and low CT density (16 HU). Red circle indicates area of spotty calcification.  
Figure 2. The CT characteristics of a culprit lesion in the 51-year-old male patient 
without post-PCI TnT elevation ≥3× the upper limit of normal. Coronary angiogram (A) 
and multiplanar reconstructed image (B) show significant stenosis in the mid left anterior 
descending artery (LAD). Cross-sectional images show the proximal reference (C), culprit 
lesion (D), and distal reference (E). The lesion has no positive remodeling (remodeling 
index: 0.98) and CT density is 76 HU. 
Figure 3. Percentage of individuals with any plaque subtype (A) and any calcified type (B) 
according to the presence or absence of post-PCI cardiac troponin T (cTnT) elevation ≥3× the 
upper limit of normal. NCP = noncalcified plaque; MP = mixed plaque; CP = calcified 
plaque. 
Table 1. Clinical Characteristics of the Study Population 
Characteristic 
Group I 
(cTnT Elevation ≥3×) 
(n = 36) 
Group II 
(cTnT Elevation <3×) 
(n = 71) 
p Value 
Age (yrs) 64 ± 10 66 ± 9 0.219 
Male sex, (%) 30 (83%) 54 (76%) 0.379 
Hypertension (%) 22 (61%) 54 (76%) 0.112 
Dyslipidemia (%) 30 (83%) 55 (77%) 0.472 
Diabetes (%) 17 (47%) 35 (49%) 0.671 
Smoking (%) 22 (61%) 50 (70%) 0.147 
LDL cholesterol (mg/dl) 100.4 ± 26.7 92.6 ± 22.9 0.151 
HDL cholesterol (mg/dl) 46.9 ± 17.0 49.5 ± 15.0 0.467 
Triglyceride (mg/dl) 137 (90.5-195)* 129 (82.5-195)* 0.802 
C-reactive protein (mg/l) 1.50 (0.65-3.50)* 1.00 (0.60-2.50)* 0.195 
Medications     
  Beta-blocker 12 (33%) 26 (37%) 0.737 
  ACE-inhibitor/ARB 17 (48%) 34 (49%) 0.953 
  Calcium channel blocker 16 (45%) 44 (63%) 0.125 
  Statin 23 (64%) 53 (75%) 0.234 
Values are presented as mean ± SD except as noted.   *Median and interquartile range. 
   ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; cTnT = cardiac 
troponin T; HDL = high-density lipoprotein; LDL = low-density lipoprotein. 
2 
Table 2. Culprit Lesion and Procedural Characteristics 
Characteristic 
Group I 
(cTnT Elevation ≥3×) 
(n = 36) 
Group II 
(cTnT Elevation <3×) 
(n = 71) 
p Value 
Target vessel    
  LAD (%) 21 (58%) 37 (52%) 0.541 
  RCA (%) 7 (19%) 19 (26%) 0.398 
  LCX (%) 8 (22%) 15 (21%) 0.896 
  Type B2/C lesion (%) 16 (45%) 30 (43%) 0.789 
  Bifurcation (%) 10 (28%) 19 (27%) 0.953 
Procedural characteristics    
  Number of stents  1.22 ± 0.50 1.14 ± 0.45 0.373 
  Stent size (mm) 2.82 ± 0.36 2.79 ± 0.54 0.789 
Transient no reflow (%) 6 (16%) 2 (3%) 0.012 
MDCT measurements    
  Lesion EEM (mm2) 15.6 ± 1.1 14.1 ± 0.8 0.252 
  Lesion MLA (mm2) 2.62 ± 1.44 2.88 ± 1.27 0.381 
  Lesion length (mm) 16.7 ± 4.2 14.1 ± 5.1 0.012 
  Remodeling index 1.20 ± 0.18 1.04 ± 0.15 <0.001 
  Positive remodeling (%)  29 (80%) 24 (32%) <0.001 
  CT attenuation value (HU)  43.0 (26.5-75.7)* 94.0 (65.0-109.0)* <0.001 
  Ring-like enhancement (%) 11 (31%) 8 (11%) 0.016 
Values are presented as mean ± SD except as noted.  *Median and interquartile range. 
CT = computed tomography; cTnT = cardiac troponin T; EEM = external elastic membrane 
cross-sectional area; HU = Hounsfield units; LAD = left anterior descending; LCX = left 
circumflex; MDCT = multidetector computed tomography; MLA = minimum lumen area; 
RCA = right coronary artery.  
3 
Table 3. Univariate and Multivariate Logistic Regression Analyses for Prediction of 
Cardiac Troponin Elevation 
 Univariate Analysis  Multivariate Analysis 
Factor OR 95% CI p Value  OR 95% CI p Value 
Age 1.03 0.98-1.08 0.161  1.02 0.96-1.07 0.522 
EEM 1.04 0.96-1.12 0.272     
Lesion length 1.12 1.02-1.23 0.012  1.07 0.97-1.20 0.187 
RI > 1.05 8.65 3.45-24.2 <0.001  4.54 1.36-15.9 0.014 
CT value < 55 HU 9.25 3.79-24.1 <0.001  2.03 0.57-7.05 0.265 
Spotty calcification 7.04  2.71-19.7 <0.001  4.27  1.30-14.8 0.016 
Log CRP 1.29  0.48-1.22 0.271     
Statin use 0.57 0.22-1.44 0.237     
   CI = confidence interval; CRP = C-reactive protein; CT = computed tomography; EEM = 
external elastic membrane cross-sectional area; HU = Hounsfield units; OR = odds ratio; RI = 
remodeling index. 
4 
Table 4. Diagnostic Accuracy of CT Characteristics for Prediction of Cardiac 
Troponin Elevation 
Factor 
Sensitivity 
(%) 
Specificity 
(%) 
PPV 
(%) 
NPV 
(%) 
Accuracy 
(%) 
CT value < 55 HU 69 80 64 84 77 
RI > 1.05 80 68 56 87 72 
Spotty calcification 50  88 69 78 76 
CT value < 55 HU + RI > 1.05 67 85 69 83 79 
CT value < 55 HU + RI >1.05 + 
spotty calcification 
47 98 94 79 81 
CT value < 55 HU or RI > 1.05 83 63 54 88 70 
CT value < 55 HU or RI > 1.05 
or spotty calcification 
86 58 52 90 68 
CT = computed tomography; HU = Hounsfield units; RI = remodeling index. 
 




